Creating targeted delivery methods for beta cell therapies in diabetes
Official title: Development of platforms for beta cell-specific delivery and ligand discovery
Funded at Broad Institute, INC. · NIH-10871834 · Data updated 2026-11-12
This study is exploring new ways to help people with type 1 diabetes by finding better methods to deliver treatments directly to the insulin-producing cells in the pancreas, which could lead to more effective and lasting solutions for managing their condition.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $962,401 |
| NIH project number | 5U01DK137242-02 |
| Project ID | NIH-10871834 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with type 1 diabetes who may benefit from improved beta cell function.
✕Less likely to help
Patients with type 2 diabetes or those who do not have a functioning pancreas may not benefit from this research.
What this research studies
This research focuses on improving treatments for patients with type 1 diabetes by developing new methods to deliver therapies specifically to beta cells in the pancreas. Current treatments rely on insulin injections and islet transplants, which have significant limitations, including donor scarcity and immune rejection. The research aims to use chemical biology techniques to enhance the proliferation of beta cells, potentially leading to more effective and long-lasting therapies. By targeting the release of therapeutic agents directly to beta cells, the hope is to improve patient outcomes and reduce the need for insulin dependence.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for type 1 diabetes, reducing the need for insulin therapy and improving patients' quality of life.
How similar studies have gone: While the approach of targeting beta cell therapies is innovative, similar research has shown promise in enhancing beta cell function and proliferation.
Where this research is happening
-
Broad Institute, INC.
Cambridge, United States Active
Researchers
- Principal investigator: Choudhary, Amit — Broad Institute, INC.
- Study coordinator: Choudhary, Amit
Related research
Other NIH-funded projects on the same topics.
-
Broad-Color: A Center to Accelerate All of Us Genomics
A national effort to speed up personalized medicine by expanding genomic data and clinical insight for All of Us participants.
-
Common Fund data knowledge center to make big data insights easy to use
A project to make NIH Common Fund datasets easy to find, understand, and use for researchers by turning them into trusted, clearly explained knowledge that supports big data discoveries.
-
Massive-scale genomic risk assessment to inform precision medicine for diabetes
A large study aims to map how genetic differences influence different forms of diabetes to guide personalized care.
-
Massive-scale genetic risk profiling to guide personalized diabetes care
A large NIH-funded project will study how many diabetes-related genetic variants influence risk across diverse populations to help tailor prevention and treatment.
-
Asian Bipolar Genetics Network study
This project studies the genetics of bipolar disorder in East and South Asian people to better understand risk factors and how they may affect diagnosis and care.
-
Broad-Color: A Genomic Center to Accelerate All of Us for Better Health
A national genomic resource project will expand and speed up how researchers use genetic data from All of Us participants to improve understanding, diagnosis, and treatment of human diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.